Unlock instant, AI-driven research and patent intelligence for your innovation.

Phenyl acetamide derivative

A technology of phenylacetamide and derivatives, which is applied in the field of new phenylacetamide derivatives and can solve problems such as unspecified compounds

Inactive Publication Date: 2010-12-15
ASTELLAS PHARMA INC
View PDF31 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the compounds of the present invention are not specifically disclosed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phenyl acetamide derivative
  • Phenyl acetamide derivative
  • Phenyl acetamide derivative

Examples

Experimental program
Comparison scheme
Effect test

manufacture example 1

[0216] To a 60% solution of sodium hydride (496 mg) in DMF (10 mL) was added a solution of 1H-pyrazol-3-amine (1.03 g) in DMF (5 mL) under ice-cooling and stirred at room temperature for 30 minutes. A solution of [(3-bromopropoxy)methyl]benzene (2.93 g) in DMF (10 mL) was added under ice-cooling, followed by stirring at room temperature overnight. Saturated saline and saturated aqueous sodium bicarbonate solution were added, followed by extraction with chloroform. The organic layer was dried over anhydrous magnesium sulfate and concentrated. The obtained crude product was purified by silica gel column chromatography (hexane:ethyl acetate=1:1-1:3) to obtain 1-[3-(benzyloxy)propyl]-1H as a pale yellow oil - Pyrazol-3-amine (835 mg).

manufacture example 2

[0218] Add bromocyclopropane (41.6g), potassium carbonate (54.8g) and triphenylmethanethiol (1.46g) in the DMF (500mL) solution of 2-bromothiophenol (50g), and internal temperature 80 Stir at °C for 24 hours. After cooling to room temperature, water and ethyl acetate were added, and the organic layer was separated. The organic layer was washed with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain 1-bromo-2-(cyclopropylthio)benzene (49.3 g).

manufacture example 3

[0220] To a suspension of aluminum chloride (40.2 g) in dichloromethane (1200 mL) was added dropwise ethyl chloro(oxo)acetate (32.3 g) at 0°C, followed by stirring at the same temperature for 1 hour. A dichloromethane (280 mL) solution of 1-bromo-2-(cyclopropylthio)benzene (49.3 g) was added dropwise while keeping the reaction liquid below 5° C., and stirred at room temperature for 1 hour. The reaction solution was cooled to 0°C, and water was added to stop the reaction. The reaction solution was extracted with ethyl acetate, and the organic layer was washed successively with water, saturated aqueous sodium bicarbonate solution and saturated brine. After drying over anhydrous magnesium sulfate, it was concentrated. The residue was purified by silica gel column chromatography to obtain ethyl [3-bromo-4-(cyclopropylthio)phenyl](oxo)acetate (29.8 g).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a compound which is useful as a GK-activator. Intensive studies are made on phenyl acetamide derivatives. As a result, it is confirmed that a phenyl acetamide derivative having a sulfonyl group and a cycloalkyl group on a phenyl group therein and a heteroaryl group on a nitrogen atom in an amide therein has a good GK-activating activity. The compound is useful as a therapeutic agent for diabetes, particularly type-2 diabetes, since the compound has a good GK-activating activity.

Description

technical field [0001] The present invention relates to novel phenylacetamide derivatives useful as medicines, especially as therapeutic agents for diabetes. Background technique [0002] GK (glucokinase (ATP: D-hexose 6-phosphotransferase, EC2.7.1.1)) is an enzyme that phosphorylates six carbon sugars expressed in the pancreas and liver. In recent years, it has also been found in the brain exist. This enzyme belongs to the hexokinase family and is also known by the alias hexokinase IV. Compared with other hexokinases, GK has the following characteristics: 1) low affinity to substrate glucose, showing a Km value close to blood glucose concentration; 2) not inhibited by the enzyme reaction product 6-phosphate glucose; 3) The molecular weight is about half that of other hexokinases, namely 50kDa. [0003] The human glucokinase gene is located on chromosome 7p13 as a single gene, which is regulated by different tissue-specific promoters separated by more than 30kb in pancrea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D213/80A61K31/415A61K31/4155A61K31/426A61K31/427A61K31/437A61K31/44A61K31/497A61P3/10A61P43/00C07D231/40C07D241/20C07D277/20C07D277/46C07D405/12C07D417/12C07D513/04
CPCC07D231/40C07D239/42C07D285/135C07D241/20C07D213/75C07D409/12C07D513/04C07D405/12C07D241/26C07D413/12C07D285/08C07D241/28C07D277/56C07D261/14C07D263/48C07D277/54C07D405/14C07D277/46C07D417/12C07D213/80A61P3/00A61P3/04A61P43/00A61P3/10C07D413/06C07D413/08
Inventor 早川昌彦城户义幸二川原充启奥村光晶金井章槙圭介网野伸明
Owner ASTELLAS PHARMA INC